English

Call Out Primary

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras aliquam purus viverra justo tristique, id posuere enim commodo.

 

Call Out Secondary

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras aliquam purus viverra justo tristique, id posuere enim commodo.

 

Funding Rates of R01 Applications from Early Stage Investigators

NIH uses funding rates as a metric for describing the likelihood of an applicant getting funded. Funding rate is defined as the number of awardees divided by the number of unique applicants in a fiscal year. Below, we provide NIDCR funding rates for Early Stage Investigator (ESIs) R01 applications.

NIDCR funds research that aims to provide scientific solutions to help end the opioid crisis.
NIDCR supports basic, translational, and clinical research studies to advance the development and use of salivary biomarkers and devices that use saliva samples to easily, accurately, and rapidly detect diseases or monitor health status.
NIDCR supports basic, translational, and clinical research to develop evidence-based regenerative medicine therapies and speed their translation from the laboratory to the clinic.